Murphy & Mullick Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Murphy & Mullick Capital Management's MRK Position: Q2 2026 in Review
Murphy & Mullick Capital Management increased its Merck (MRK) stake by 1.3% in Q2 2026, buying an estimated $17.7K and bringing the position to 11,473 shares worth $1.47M. The position accounts for 0.91% of the portfolio, ranked #25.
Murphy & Mullick Capital Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Murphy & Mullick Capital Management held 11,473 shares of Merck worth $1.47M as of Q2 2026.
- Murphy & Mullick Capital Management bought 151 Merck shares in Q2 2026, an estimated $17.7K.
- Merck made up 0.91% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #25 holding.
- Murphy & Mullick Capital Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
- 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.